Molecular Therapies in Thyroid CancerReport as inadecuate




Molecular Therapies in Thyroid Cancer - Download this document for free, or read online. Document in PDF available to download.

Northwestern University, Feinberg School of Medicine, Division of Hematology- Oncology, Department of Medicine, 676 North St. Clair Street, Suite 850, Chicago, IL 60611, USA





*

Author to whom correspondence should be addressed.



Abstract Thyroid cancer is a common diagnosis with greater than 34,000 cases per year in the United States. Early stage thyroid cancer is often managed with surgical intervention and radioactive iodine; however, for recurrent or metastatic disease, the treatment options, historically, have been limited to chemotherapy. Chemotherapy for metastatic thyroid cancer has been of limited efficacy. Encouragingly, molecular therapeutics have played a greater role in managing patients with advanced disease. These agents work primarily through disruption of tyrosine kinase pathways. This review will discuss the expanding role of molecular targets in managing patients with advanced thyroid cancer. View Full-Text

Keywords: advanced thyroid cancer; molecular therapy; tyrosine kinase inhibitors advanced thyroid cancer; molecular therapy; tyrosine kinase inhibitors





Author: Timothy Huyck and Mark Agulnik *

Source: http://mdpi.com/



DOWNLOAD PDF




Related documents